Skip to main content
SpringerLink
Log in

Utility of Liver Transplantation Within the Bounds of Non-futility

  • Liver Transplantation (D Mulligan and Ramesh Batra, Section Editors)
  • Published:
Current Transplantation Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To evaluate the measures of utility of liver transplant within the bounds of non-futility for controversial and high-risk scenarios associated with greatest transplant benefit and also possibilities of high futility.

Recent Findings

Liver organ allocation policies are routinely adjusted to be in line with the Final Rule, maximizing transplant opportunities and minimizing futile transplants. Transplanting patients with high survival benefit is the construct of the liver allocation models with “sickest first” approach, but such policies have unintended consequences of futile transplants which raise ethical controversies and moral burdens on transplant physicians.

Summary

Various adjustments are proposed to make the liver organ allocation models effective in high-risk scenarios which yield greatest transplant benefit for patients and satisfaction for the transplant physicians while minimizing disappointment among them from reduced futile efforts. They also offer ethical and effective allocation strategies of scare medical resource, i.e., liver.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. •• Introduction to the principles of morals and legislation. ed. J.H Burns and H.L.A. Hart (The Athlone Press, 1970), pp. xliii, 343. Reprinted in paperback with new introduction by F. Rosen (Clarendon Press, Oxford, 1996), pp.cxii, 343. https://www.ucl.ac.uk/bentham-project/publications/collected-works-jeremy-bentham/introduction-principles-morals-and-legislation/ipml UCL Bentham Project. Retrieved March 1st 2020. CANONIC study of the EASL-CLIF consortium of 12 European countries, the largest study to date to analyze ACLF grades and their correlation to mortality with and without salvage liver transplant.

  2. Crimmins JE. Jeremy Bentham. Summer 2019 ed: Metaphysics Research Lab, Stanford University; 2019.

  3. Electronic Code of Federal Regulations, 64 FR 56659, Oct. 20, 1999, as amended at 64 FR 71626, Dec. 21, 1999.

  4. Batra RK. Ethical implications in donor and recipient utilization for liver transplant. Current Transplantation Reports. 2019;6(4):322–7.

    Google Scholar 

  5. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–70.

    CAS  PubMed  Google Scholar 

  6. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130(6):1652–60.

    PubMed  Google Scholar 

  7. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359(10):1018–26.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Panchal HJ, Durinka JB, Patterson J, Karipineni F, Ashburn S, Siskind E, et al. Survival outcomes in liver transplant recipients with model for end-stage liver disease scores of 40 or higher: a decade-long experience. HPB. 2015;17(12):1074–84.

    PubMed  PubMed Central  Google Scholar 

  9. Artru F, Samuel D. Approaches for patients with very high MELD scores. JHEP Reports. 2019;1(1):53–65.

    PubMed Central  Google Scholar 

  10. Choudhury A, Kumar M, Sharma BC, Maiwall R, Pamecha V, Moreau R, et al. Systemic inflammatory response syndrome in acute-on-chronic liver failure: relevance of ‘golden window’: a prospective study. J Gastroenterol Hepatol. 2017;32(12):1989–97.

    CAS  PubMed  Google Scholar 

  11. Petrowsky H, Rana A, Kaldas FM, Sharma A, Hong JC, Agopian VG, et al. Liver transplantation in highest acuity recipients. Ann Surg. 2014;259(6):1186–94.

    PubMed  Google Scholar 

  12. Akamatsu N, Sugawara Y, Kokudo N. Acute liver failure and liver transplantation. Intractable Rare Dis Res. 2013;2(3):77–87.

    PubMed  PubMed Central  Google Scholar 

  13. Germani G, Theocharidou E, Adam R, Karam V, Wendon J, O'Grady J, et al. Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol. 2012;57(2):288–96.

    PubMed  Google Scholar 

  14. https://srtr.transplant.hrsa.gov/annual_reports/2018/Liver.aspx (accessed March 5th 2020).

  15. O'Grady J. Timing and benefit of liver transplantation in acute liver failure. J Hepatol. 2014;60(3):663–70.

    PubMed  Google Scholar 

  16. Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41(5):1179–97.

    PubMed  Google Scholar 

  17. Allen AM, Kim WR, Moriarty JP, Shah ND, Larson JJ, Kamath PS. Time trends in the health care burden and mortality of acute on chronic liver failure in the United States. Hepatology. 2016;64(6):2165–72.

    PubMed  Google Scholar 

  18. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426–37.e9.

    PubMed  Google Scholar 

  19. •• Gustot T, Fernandez J, Garcia E, Morando F, Caraceni P, Alessandria C, et al. Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis. Hepatology. 2015;62(1):243–52 CANONIC study of the EASL-CLIF consortium of 12 European countries, the largest study to date to analyze ACLF grades and their correlation to mortality with and without salvage liver transplant.

    PubMed  Google Scholar 

  20. Thuluvath PJ, Thuluvath AJ, Hanish S, Savva Y. Liver transplantation in patients with multiple organ failures: feasibility and outcomes. J Hepatol. 2018;69(5):1047–56.

    PubMed  Google Scholar 

  21. Choudhury AK, Sharma MK, Maiwal R, Jain P, Mahtab MA, Chawla YK, et al. The decision for liver transplant in acute on chronic liver failure (ACLF) - first week is the crucial period - analysis of the Apasl ACLF Research Consortium (AARC) prospective data of 1021 patients. J Hepatol. 2016;64(2):S151–S2.

    Google Scholar 

  22. Zheng Y-X, Zhong X, Li Y-J, Fan X-G. Performance of scoring systems to predict mortality of patients with acute-on-chronic liver failure: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2017;32(10):1668–78.

    PubMed  Google Scholar 

  23. Lee M, Lee J-H, Oh S, Jang Y, Lee W, Lee HJ, et al. CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis. Liver Int. 2015;35(1):46–57.

    PubMed  Google Scholar 

  24. Figueras J, Jaurrieta E, Valls C, Ramos E, Serrano T, Rafecas A, et al. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg. 2000;190(5):580–7.

    CAS  PubMed  Google Scholar 

  25. Figueras J, Jaurrieta E, Valls C, Benasco C, Rafecas A, Xiol X, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology. 1997;25(6):1485–9.

    CAS  PubMed  Google Scholar 

  26. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693–9.

    CAS  PubMed  Google Scholar 

  27. Batra RK, Mulligan DC. Trends and the current status of living donor liver transplant. InTech; 2018.

  28. Heimbach JK, Hirose R, Stock PG, Schladt DP, Xiong H, Liu J, et al. Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States. Hepatology. 2015;61(5):1643–50.

    PubMed  PubMed Central  Google Scholar 

  29. Parikh ND, Singal AG. Model for end-stage liver disease exception points for treatment-responsive hepatocellular carcinoma. Clinical Liver Disease. 2016;7(5):97–100.

    PubMed  PubMed Central  Google Scholar 

  30. Yao FY, Mehta N, Flemming J, Dodge J, Hameed B, Fix O, et al. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatology. 2015;61(6):1968–77.

    PubMed  PubMed Central  Google Scholar 

  31. United Nations, Department of Economic and Social Affairs, Population Division (2019). World population prospects 2019, online edition. Rev. 1

  32. Kwong A, Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, et al. OPTN/SRTR 2018 annual data report: liver. Am J Transplant. 2020;20(s1):193–299.

    PubMed  Google Scholar 

  33. Yazdanyar A, Newman AB. The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clin Geriatr Med. 2009;25(4):563–77 vii.

    PubMed  PubMed Central  Google Scholar 

  34. Malik MU, Russell SD, Pustavoitau A, Chacko M, Cosar AM, Thompson CB, et al. The predictors of post-transplant coronary events among liver transplant recipients. Hepatol Int. 2016;10(6):974–82.

    PubMed  Google Scholar 

  35. •• Vanwagner LB, Lapin B, Levitsky J, Wilkins JT, Abecassis MM, Skaro AI, et al. High early cardiovascular mortality after liver transplantation. 2014;20(11):1306–16. Excellent study co-correlating impact of perioperative coronary events with 1 year and 3 year mortality in patients after liver transplant.

  36. Quagliarello VJ. Outcomes among older adult liver transplantation recipients in the model of end stage liver disease (MELD) era. Annals of Transplantation. 2014;19:478–87.

    PubMed  PubMed Central  Google Scholar 

  37. Tovikkai C, Charman SC, Praseedom RK, Gimson AE, Van Der Meulen J. Time-varying impact of comorbidities on mortality after liver transplantation: a national cohort study using linked clinical and administrative data. 2015;5(5):e006971-e.

  38. Gil E, Kim JM, Jeon K, Park H, Kang D, Cho J, et al. Recipient age and mortality after liver transplantation: a population-based cohort study. Transplantation. 2018;102(12):2025–32.

    PubMed  PubMed Central  Google Scholar 

  39. Chen H-P, Tsai Y-F, Lin J-R, Liu F-C, Yu H-P. Recipient age and mortality risk after liver transplantation: a population-based cohort study. PLoS One. 2016;11(3):e0152324.

    PubMed  PubMed Central  Google Scholar 

  40. Johnston SD, Morris JK, Cramb R, Gunson BK, Neuberger J. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation. 2002;73(6):901–6.

    PubMed  Google Scholar 

  41. Schwartz JJ, Pappas L, Thiesset HF, Vargas G, Sorensen JB, Kim RD, et al. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience. Liver Transpl. 2012;18(4):423–33.

    PubMed  Google Scholar 

  42. Aduen JF, Sujay B, Dickson RC, Heckman MG, Hewitt WR, Stapelfeldt WH, et al. Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years. Mayo Clin Proc. 2009;84(11):973–8.

    PubMed  PubMed Central  Google Scholar 

  43. Wilson GC, Quillin RC 3rd, Wima K, Sutton JM, Hoehn RS, Hanseman DJ, et al. Is liver transplantation safe and effective in elderly (≥70 years) recipients? A case-controlled analysis. HPB. 2014;16(12):1088–94.

    PubMed  PubMed Central  Google Scholar 

  44. Hirai H, Asahi K, Yamaguchi S, Mori H, Satoh H, Iseki K, et al. New risk prediction model of coronary heart disease in participants with and without diabetes: assessments of the Framingham risk and Suita scores in 3-year longitudinal database in a Japanese population. Sci Rep. 2019;9(1):2813.

    PubMed  PubMed Central  Google Scholar 

  45. Coss E, Watt KD, Pedersen R, Dierkhising R, Heimbach JK, Charlton MR. Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels. Liver Transpl. 2011;17(1):23–31.

    PubMed  Google Scholar 

  46. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Ser A Biol Med Sci. 2001;56(3):M146–M57.

    CAS  Google Scholar 

  47. Hamerman D. Toward an understanding of frailty. Ann Intern Med. 1999;130(11):945.

    CAS  PubMed  Google Scholar 

  48. Danon-Hersch N, Rodondi N, Spagnoli J, Santos-Eggimann B. Prefrailty and chronic morbidity in the youngest old: an insight from the Lausanne cohort Lc65+. J Am Geriatr Soc. 2012;60(9):1687–94.

    PubMed  Google Scholar 

  49. Chen C-Y, Wu S-C, Chen L-J, Lue B-H. The prevalence of subjective frailty and factors associated with frailty in Taiwan. Arch Gerontol Geriatr. 2010;50:S43–S7.

    PubMed  Google Scholar 

  50. Fernández-Garrido J, Ruiz-Ros V, Buigues C, Navarro-Martinez R, Cauli O. Clinical features of prefrail older individuals and emerging peripheral biomarkers: a systematic review. Arch Gerontol Geriatr. 2014;59(1):7–17.

    PubMed  Google Scholar 

  51. •• Hanlon P, Nicholl BI, Jani BD, Lee D, McQueenie R, Mair FS. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants. The Lancet Public Health. 2018;3(7):e323–e32 Largest study to date from UK Biobank participants which analyzes frailty related survival in patients younger than 65 years, as young as 37.

    PubMed  PubMed Central  Google Scholar 

  52. Lai JC, Feng S, Terrault NA, Lizaola B, Hayssen H, Covinsky K. Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant. 2014;14(8):1870–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Linecker M, Krones T, Berg T, Niemann CU, Steadman RH, Dutkowski P, et al. Potentially inappropriate liver transplantation in the era of the "sickest first" policy - a search for the upper limits. J Hepatol. 2018;68(4):798–813.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery (Transplant), Yale University School of Medicine, Yale New Haven Transplant Center, 330 Cedar Street, New Haven, CT, 06520, USA

    Ramesh K. Batra

Authors
  1. Ramesh K. Batra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ramesh K. Batra.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Liver Transplantation

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Batra, R.K. Utility of Liver Transplantation Within the Bounds of Non-futility. Curr Transpl Rep 7, 187–193 (2020). https://doi.org/10.1007/s40472-020-00288-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40472-020-00288-w

Keywords

Search

Navigation